Category: Life Sciences
Global Life Sciences
-
Foot Care Products
... at a CAGR of 5.5% over the analysis period 2024-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in ... Read More
-
Plastic Films
... CAGR of 5.8% over the analysis period 2024-2030. LLDPE, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis period. ... Read More
-
Industrial Enzymes
... CAGR of 4.3% over the analysis period 2024-2030. Carbohydrases, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.6 Billion by the end of the analysis period. ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth in ... Read More
-
Vitamins
... 6.0% over the analysis period 2024-2030. Vitamin B, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth ... Read More
-
Urinary Catheters
... CAGR of 6.1% over the analysis period 2024-2030. Intermittent Catheters, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
-
Medicated Skin Care Products
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$2.9 Billion by the end ... Read More
-
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters
... expected to reach US$1.3 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Normal Balloon Catheter, one of the segments analyzed in the report, is expected to record a 2.6% ... Read More
-
Nucleic Acid Testing
... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
Cardiac Rhythm Management (CRM) Devices
... Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$11.3 Billion by ... Read More
-
Urodynamics Equipment and Disposables
... 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Uroflowmetry Equipment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$106.2 Million by the ... Read More
-
Organ Preservation Solutions
... at a CAGR of 4.9% over the analysis period 2024-2030. Static Cold Storage, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$161.8 Million by the end ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... reach US$57.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Stimulant, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$47.7 ... Read More
-
Calibration Services
... CAGR of 5.6% over the analysis period 2024-2030. Electrical, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the analysis period. ... Read More
-
H1N1 Vaccines
... CAGR of 5.4% over the analysis period 2024-2030. Intramuscular, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Acute Coronary Syndrome
... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More
-
Herpes Simplex Virus Infections
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes Simplex Virus Infections market ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Vertebral Compression Fracture Devices
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the ... Read More
-
e-Prescription Systems
... CAGR of 16.7% over the analysis period 2024-2030. Solutions, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.2 Billion by the end of the analysis period. ... Read More
-
Antimicrobial Plastics
... CAGR of 7.1% over the analysis period 2024-2030. Commodity Plastics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$44.6 Billion by the end of the analysis ... Read More
Research Assistance
